ProShare Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,546
| Closed | -$9.08K | – | 2146 |
|
2025
Q1 | $9.08K | Sell |
10,546
-3,175
| -23% | -$2.73K | ﹤0.01% | 2070 |
|
2024
Q4 | $23.1K | Sell |
13,721
-2,895
| -17% | -$4.86K | ﹤0.01% | 2252 |
|
2024
Q3 | $47.4K | Buy |
16,616
+2,122
| +15% | +$6.05K | ﹤0.01% | 1986 |
|
2024
Q2 | $33.9K | Sell |
14,494
-3,344
| -19% | -$7.83K | ﹤0.01% | 1782 |
|
2024
Q1 | $52.4K | Buy |
17,838
+1,497
| +9% | +$4.4K | ﹤0.01% | 1898 |
|
2023
Q4 | $48.9K | Buy |
16,341
+1,615
| +11% | +$4.83K | ﹤0.01% | 1864 |
|
2023
Q3 | $46.5K | Buy |
14,726
+80
| +0.5% | +$253 | ﹤0.01% | 1722 |
|
2023
Q2 | $56.7K | Buy |
14,646
+378
| +3% | +$1.46K | ﹤0.01% | 1759 |
|
2023
Q1 | $39.5K | Sell |
14,268
-2,181
| -13% | -$6.04K | ﹤0.01% | 1690 |
|
2022
Q4 | $29.6K | Buy |
16,449
+709
| +5% | +$1.28K | ﹤0.01% | 1785 |
|
2022
Q3 | $33K | Buy |
15,740
+691
| +5% | +$1.45K | ﹤0.01% | 1694 |
|
2022
Q2 | $40K | Buy |
15,049
+2,172
| +17% | +$5.77K | ﹤0.01% | 1728 |
|
2022
Q1 | $56K | Sell |
12,877
-4,608
| -26% | -$20K | ﹤0.01% | 2107 |
|
2021
Q4 | $91K | Buy |
+17,485
| New | +$91K | ﹤0.01% | 2217 |
|